Reposted by Ross ChelohaRetro Tech Dreams @retrotechdreams.bsky.social · 14/04/2026Myst (1993) 1344482
Ross Cheloha @rche54.bsky.social · 27/01/2026My first corresponding author publication in @jacs.acspublications.org Very proud and feeling like a bona fide chemist pubs.acs.org/doi/full/10....pubs.acs.org 260
Reposted by Ross ChelohaJanelia Research Campus @hhmijanelia.bsky.social · 15/12/2025Apply by Feb. 3 to become a Janelia Group Leader! Group Leaders drive breakthroughs & experimental approaches in imaging, molecular engineering, protein chemistry, mass spectrometry, & methods that don't yet exist. Learn more: janelia.org/groupleader 🧪 01821
Reposted by Ross ChelohaJames Checco @jameswchecco.bsky.social · 04/12/2025Consider submitting your peptide research to a special joint issue of JOC and Biochemistry on the Chemistry and Biology of Peptides! axial.acs.org/biology-and-...axial.acs.orgCall For Papers: Chemistry and Biology of Peptides | ACS Publications Chemistry BlogThis Special Issue will celebrate the chemistry and biology of peptides, from synthesis, to structure and modifications, to biology and applications, and finally to degradation. Submit your manuscript... 092
Reposted by Ross ChelohaPLOS Biology @plosbiology.org · 25/11/2025Bitopic ligands comprise a #pharmacophore & a linked moiety that bind to separate sites. @rche54.bsky.social &co show that #GPCRs that bind small molecules can be potently activated by #bitopic #nanobody -ligand conjugates to selectively target pairs of GPCRs @plosbiology.org 🧪 plos.io/4p3VOyH 033
Ross Cheloha @rche54.bsky.social · 22/11/2025So cool to read this commentary that covers our recent work! journals.plos.org/plosbiology/...journals.plos.orgNanobody-drug conjugates for targeting specific GPCR pairsBitopic ligands that engage two distinct binding sites offer exciting opportunities for finely tuned control of G protein-coupled receptor signaling. This Primer explores a recent study in PLOS Biology that reports novel nanobody-small molecule conjugates and demonstrates their logic-gated activity at co-expressed receptor pairs with improved signaling profiles. 141
Ross Cheloha @rche54.bsky.social · 20/11/2025So pleased to share the final version of this work published in @plosbiology.org ! journals.plos.org/plosbiology/...journals.plos.orgDevelopment of bitopic nanobody-ligand conjugates targeting G protein-coupled receptors and exhibiting logic-gated signalingBitopic ligands are comprised of a pharmacophore and a linked moiety that bind to separate sites. This study shows that G-protein coupled receptors (GPCRs) that bind small molecules can be potently ac... 283
Ross Cheloha @rche54.bsky.social · 03/09/2025Read this in a paper and it was totally new to me (after 18 years in biochemistry research): “Peptides translated from the sense and antisense strands of DNA interact specifically, analogous to the complementary interactions between DNA double strands.” Is this widely studied/actually true?? 🤯 120
Reposted by Ross ChelohaJeremy Baskin @jeremybaskin.bsky.social · 25/08/2025Faculty opening in Cornell Chemistry at the Assistant Professor level in the area of chemical biology, broadly defined! academicjobsonline.org/ajo/jobs/30338 #chemjobsacademicjobsonline.orgCornell University, Chemistry and Chemical Biology Job #AJO30338, WDR-00054776 Assistant Professor - Chemistry and Chemical Biology, Cornell University (Ithaca, NY), Chemistry and Chemical Biology, Cornell University, Ithaca, New York, US 14952
Reposted by Ross ChelohaFanny Chasseloup @fannychasseloup.bsky.social · 17/07/2025Last day at #ENDO2025 was great! Amazing symposium on bone and calcium disorders 🦴 by @rche54.bsky.social @MichailLionakis @MichaelMannstadt with great talks on GPCRs and nanobodies, JAK inhibitors in APECED syndrome & new PTH therapies 🤩 041
Reposted by Ross ChelohaJames Checco @jameswchecco.bsky.social · 23/06/2025This Wednesday and Thursday is the VIRTUAL Nebraska Drug Discovery and Development Pipeline Symposium! Registration is still open! Plenary speakers include Brian Kobilka and Virginia Man-Yee Lee. #chemsky, you should attend! research.unl.edu/blog/annual-...research.unl.eduAnnual Nebraska Drug Discovery and Development Pipeline symposium June 25-26World-renowned experts will offer their insights during the fifth annual ND3P Symposium, set for June 25-26. The symposium will be virtual and highly interactive. 031
Ross Cheloha @rche54.bsky.social · 22/05/2025Check out the final published product in Journal of Biological Chemistry! www.jbc.org/article/S002...jbc.orgEvaluation of Alphafold modeling for elucidation of nanobody-peptide epitope interactionsModels of Ab-antigen complexes can be used to understand interaction mechanisms and for improving affinity. This study evaluates the use of the protein structure prediction algorithm AlphaFold (AF) fo... 010
Reposted by Ross ChelohaGeorge Burslem @gburslem.bsky.social · 01/05/2025Excited to see this out in @science.org today!! www.science.org/doi/10.1126/...science.orgIntracellular protein editing enables incorporation of noncanonical residues in endogenous proteinsThe ability to study proteins in their native cellular context is crucial to our understanding of biology. In this work, we report a technology for intracellular protein editing, drawing from split in... 613552
Reposted by Ross ChelohaFreddy E Escorcia, MD/PhD @freddyeescorcia.bsky.social · 14/04/2025Next up, a collaboration with Ross Cheloha's group (@rche54 @rche54.bsky.social) and @MitchellHo leveraging a novel self-labeling approach for site-specific modification of nanobodies for biological applications. doi.org/10.1002/advs... 3/5 111
Reposted by Ross ChelohaFreddy E Escorcia, MD/PhD @freddyeescorcia.bsky.social · 14/04/2025It's been a while since I posted on some of the ☢️ #radiopharmaceuticals ☢️ work we've been brewing. Let's fix that... 🧵👇 1/5 141
Reposted by Ross ChelohaJordan Meier @doc-jlmeier.bsky.social · 10/04/2025Great news: NIH postbac program is recruiting again! If your grad school plans were affected by program cutbacks or admissions freezes this year I highly encourage you to apply, this could be a perfect opportunity. Please repost. www.training.nih.gov/research-tra...training.nih.gov 6207195
Reposted by Ross ChelohaCarolyn Bertozzi @carolynbertozzi.bskyverified.social · 26/03/2025Check out our new review on induced proximity modalities (#TPD and a lot more!) aimed cell surface targets @naturebiotech.bsky.social, spearheaded by postdocs Nick Till and "Rahm" Ramanathan www.nature.com/articles/s41...nature.comInduced proximity at the cell surface - Nature BiotechnologyTechnologies to modulate induced proximity at the cell surface advance the manipulation of diverse biological responses. 07922
Reposted by Ross ChelohaAlphaFold Unofficial @alphafold.bsky.social · 20/03/2025The findings suggest that optimizing input parameters and refining competition-based modeling approaches may enhance predictive accuracy for antibody-antigen interactions. Intriguing. 021
Ross Cheloha @rche54.bsky.social · 20/03/2025Excited to share a preprint covering a collaborative project from my group, the Bewley lab (NIDDK), and the Pierce lab (University of Maryland) describing our first foray into assessing Alphafold for predicting peptide-nanobody interactions (1/n) www.biorxiv.org/content/10.1...biorxiv.orgEvaluation of Alphafold modeling for elucidation of nanobody-peptide epitope interactionsModels of Ab-antigen complexes can be used to understand interaction mechanisms and to improve affinity. This study evaluates the use of the protein structure prediction algorithm AlphaFold (AF) for e... 2121
Ross Cheloha @rche54.bsky.social · 13/03/2025Proud to share this work from my group in the intramural research program at NIH! We describe a new kind of conjugate made from a small molecule adenosine analog linked to a GPCR targeting nanobody to make antibody drug conjugates that potently and specifically activate signaling (1/n) 🧪 #chembio 1215
Reposted by Ross ChelohabioRxivpreprint @biorxivpreprint.bsky.social · 12/03/2025Nanobody-based conjugates targeting small molecule-binding GPCRs and exhibiting logic-gated signaling www.biorxiv.org/content/10.1101/202… 021
Ross Cheloha @rche54.bsky.social · 23/02/2025Proud to share this publication about the development of a new method for visualizing tumors! This work resulted from a close collaboration among 3 groups. (1/n) 🧪@freddyeescorcia.bsky.social advanced.onlinelibrary.wiley.com/doi/10.1002/...advanced.onlinelibrary.wiley.comGeneration of Site‐Specifically Labeled Affinity Reagents via Use of a Self‐Labeling Single Domain AntibodySeveral methods have been used to label antibodies to facilitate visualization of cognate targets. Here, we leverage a new variety of conjugation chemistry, based on a crosslinking nanobody, to label... 140
Reposted by Ross ChelohaMatt Hall @cispt2.bsky.social · 15/01/2025Our NCATS research program has a history of collaborating and partnering to get treatments to patients. One of my first goals as SD was to capture and share our success in one place - and here it is! 4 approvals and 56 INDs to date - not bad for 12 years old! ncats.nih.gov/research/our... 163
Reposted by Ross ChelohaJeremy Baskin @jeremybaskin.bsky.social · 14/01/2025Overjoyed and honestly relieved to share a Chem Rev magnum opus from Brian Chen & Julia Li titled Synthetic Lipid Biology! In it, we organize efforts across numerous fields to create, manipulate, and analyze lipids and biomembranes. Check it out! doi.org/10.1021/acs.... #lipidtime #chemsky #chembio 88825
Reposted by Ross ChelohaOlalla Vázquez @olallalab.bsky.social · 26/12/2024🎄Xmas gift!🎁Joint work with #OliverHantschel in @naturecomms.bsky.social 💥! Huge kudos 💪🏼😻 Nina 👩🔬 for leading as 1st author & Frank 👨🏼🔬 for training her like a pro❤️ Small delay😅 -my👵broke her hip🤦🏼♀️-loved ones always come first❤️surgery went good💪🏼🤩Let's celebrate🥳🥂! #ChemBio www.nature.com/articles/s41...nature.comDevelopment of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase - Nature CommunicationsIn this work, the authors develop mirror-image monobodies (Mb) made of D-amino acids against the BCR::ABL1 SH2 domain with high binding affinities. The heterochiral Mb-SH2 structures reveal an unusual... 0306
Reposted by Ross ChelohaPossu Huang Lab @possuhuanglab.bsky.social · 17/12/20241/ In two back-to-back papers, we present our de novo TRACeR platform for targeting MHC-I and MHC-II antigens TRACeR for MHC-I: go.nature.com/4gcLzn5 TRACeR for MHC-II: go.nature.com/4gj5OQk 29129
Ross Cheloha @rche54.bsky.social · 12/12/2024A thought provoking scenario: what would happen if "mirror" (reverse chirality) microbe were created and released? The time estimate (10 years) seems long to me as there's been incredible progress in making mirror enzymes. You don't need much of a few mirror enzymes for a self sustaining cascade..🧪science.orgConfronting risks of mirror lifeBroad discussion is needed to chart a path forward. 030
Reposted by Ross ChelohaMike Feigin 🥯 @mikefeigin.bsky.social · 11/12/2024Are you a senior PhD student or postdoc? Do you have a cool science story to tell? Do you want to visit Buffalo when the weather is perfect? Then apply for the Emerging Leaders Seminar Series at Roswell Park! DM or email me with questions. (RT please!) www.roswellpark.org/education/pr...roswellpark.orgEmerging Leaders in Cancer Research Seminar SeriesThe Roswell Park Emerging Leaders in Cancer Research Seminar Series features lectures by outstanding junior scientists from around the country on a diverse range of cancer-focused topics. This include... 06249
Ross Cheloha @rche54.bsky.social · 10/12/2024Very nice work using nanobodies, sortagging, click chemistry, and multivalent conjugates--right up my alley! Congrats to the authors www.cell.com/cell/fulltex...cell.comMultimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironmentA triple orthogonal linker (T-Linker)-based programmable platform enables integration of therapeutic modules into multimodal targeting chimeras (Multi-TACs) for tumor-targeted co-engagement of different immune cells within the tumor-immune microenvironment. 032
Reposted by Ross ChelohaAlice Ting @aliceyting.bsky.social · 04/12/2024Could one envision a synthetic receptor technology that is fully programmable, able to detect diverse extracellular antigens – both soluble and cell-attached – and convert that recognition into a wide range of intracellular responses, from gene expression and real-time fluorescence to modulation.. 33434138
Reposted by Ross ChelohaRoss Cheloha @rche54.bsky.social · 27/11/2024Happy and proud to see this paper from postdoc Shubhra Saha and myself come out in JACS Au! This was a project where I really had no idea if we could get the design to work but IT DID and I think it’s quite cool. A brief rundown 1/npubs.acs.orgChemically Induced Dimerization via Nanobody Binding Facilitates in Situ Ligand Assembly and On-Demand GPCR ActivationMethods that enable the on-demand synthesis of biologically active molecules offer the potential for a high degree of control over the timing and context of target activation; however, such approaches often require extensive engineering to implement. Tools to restrict the localization of assembly also remain limited. Here we present a new approach for stimulus-induced ligand assembly that helps to address these challenges. This methodology relies on the high affinity and specificity recognition exhibited by antibody fragments (nanobodies, Nbs). By using Nbs that recognize short peptide epitopes to create semisynthetic conjugates, we develop a bioengineering platform termed peptide epitope dimerization (PED) in which the addition of heterodimeric peptide composed of two Nb epitopes stimulates the proximity-induced synthesis of a functional ligand for the parathyroid hormone receptor-1, a G protein-coupled receptor. We further demonstrate that high efficiency assembly can be achieved on the cell surface via Nb-based delivery of template. This approach opens the door for the on-demand generation of bioactive receptor ligands preferentially at a desired biological niche. 3287
Reposted by Ross ChelohaAlexandre Bonvin @amjjbonvin.bsky.social · 02/12/2024AF3 has clearly not solved the antibody-antigen prediction problem seeing the CASP16 results… 0202
Reposted by Ross ChelohaAbhishek Chatterjee @achemsynbio.bsky.social · 01/12/2024Got the chance to put together the "Click of Chemical Biologists" starter pack v1 and v2 over the Thanksgiving Break. Feel free to ping me on who else I might be missing! V1: go.bsky.app/3P5i7nJ V2: go.bsky.app/Cr4ej7 128232
Reposted by Ross ChelohaITYSL memes 💦🥩 @ityslmemes.com · 29/11/2024It's not a big deal, you made a big dinner you served too many sides I ate the Thanksgiving dinner and 924629
Ross Cheloha @rche54.bsky.social · 27/11/2024Happy and proud to see this paper from postdoc Shubhra Saha and myself come out in JACS Au! This was a project where I really had no idea if we could get the design to work but IT DID and I think it’s quite cool. A brief rundown 1/npubs.acs.orgChemically Induced Dimerization via Nanobody Binding Facilitates in Situ Ligand Assembly and On-Demand GPCR ActivationMethods that enable the on-demand synthesis of biologically active molecules offer the potential for a high degree of control over the timing and context of target activation; however, such approaches often require extensive engineering to implement. Tools to restrict the localization of assembly also remain limited. Here we present a new approach for stimulus-induced ligand assembly that helps to address these challenges. This methodology relies on the high affinity and specificity recognition exhibited by antibody fragments (nanobodies, Nbs). By using Nbs that recognize short peptide epitopes to create semisynthetic conjugates, we develop a bioengineering platform termed peptide epitope dimerization (PED) in which the addition of heterodimeric peptide composed of two Nb epitopes stimulates the proximity-induced synthesis of a functional ligand for the parathyroid hormone receptor-1, a G protein-coupled receptor. We further demonstrate that high efficiency assembly can be achieved on the cell surface via Nb-based delivery of template. This approach opens the door for the on-demand generation of bioactive receptor ligands preferentially at a desired biological niche. 3287
Reposted by Ross ChelohaEllis Crawford @elliscrawford.bsky.social · 25/11/2024Did some tidying up of the links for chemistry related starter packs, arranged loosely by subject area, and added who maintains the list so you know who to speak with if you'd like to be added! tinyurl.com/ChemSkyStart... #ChemSky #Chemistry #Chemists #StarterPacks 🧪tinyurl.comBluesky Chem Starter Packs 2217075
Reposted by Ross ChelohaRyan Nanni @celebrityhottub.bsky.social · 23/11/2024Nebraska can't blow this right 35712
Reposted by Ross ChelohaRoss Cheloha @rche54.bsky.social · 12/11/2024Reposting for the new BlueSky arrivals! My group develops new tools to study cell surface proteins using organic chemistry and antibody engineering with a focus on GPCR pharmacology 🧪 #NewPI 062
Reposted by Ross ChelohaMatt Hartings @matthartings.bsky.social · 20/11/2024Hey ChemSky Has anyone put together typical startup expectations for new assistant professors lately? I know that every now and then folks get together to try and crowdsource info like this. Any help greatly appreciated! cc @chemjobber.bsky.social 31611
Reposted by Ross ChelohaFreddy E Escorcia, MD/PhD @freddyeescorcia.bsky.social · 14/11/2024Perhaps, a re-introduction is in order. I am an oncologist at the NCI/NIH who uses radiation to treat cancers. Clinically, I am interested in cancers of the gut. My lab designs, engineers, and tests☢️ #radiopharmaceuticals☢️ for imaging and treatment of cancers. Where the nerds at?media.tenor.comtwo men in suits and ties are standing next to each other in an office . one of them is wearing a santa hat .ALT: two men in suits and ties are standing next to each other in an office . one of them is wearing a santa hat . 7544
Ross Cheloha @rche54.bsky.social · 12/11/2024Reposting for the new BlueSky arrivals! My group develops new tools to study cell surface proteins using organic chemistry and antibody engineering with a focus on GPCR pharmacology 🧪 #NewPI 062
Reposted by Ross ChelohaRoss Cheloha @rche54.bsky.social · 07/11/2023I work as a chemist and chemical biologist at the NIH intramural research program. 6% of intramural labs associate their work with "chemical biology". Here's an interesting article about the history of ("the demise of") chemistry in NIH intramural research labs irp.nih.gov/catalyst/31/... 062
Reposted by Ross ChelohaJames Checco @jameswchecco.bsky.social · 12/11/2024Our recent paper in JACS utilizes affinity-driven azo coupling to study peptide-receptor interactions on living cells. This can be useful to probe ligand signaling, study receptor dynamics, or identify new peptide-receptor interactions! #chemsky pubs.acs.org/doi/10.1021/...pubs.acs.orgAffinity-Driven Aryl Diazonium Labeling of Peptide Receptors on Living CellsPeptide–receptor interactions play critical roles in a wide variety of physiological processes. Methods to link bioactive peptides covalently to unmodified receptors on the surfaces of living cells ar... 021
Ross Cheloha @rche54.bsky.social · 11/11/2024The United Nations says 2024 is the year of the Camelids! Love to see nanobodies getting some international appreciation www.scienceinschool.org/article/2024...scienceinschool.orgInspired by camelids: nanobodies are a magnificent molecular velcro – Science in SchoolIt is the Year of Camelids! The year 2024 was designated the United Nations International Year of Camelids. Camelid animals, including alpacas, camels, 000
Ross Cheloha @rche54.bsky.social · 31/10/2024Probably my favorite line of music to sing of all time. Really rolls off the tongue! 001